Intravesical CD74 and CXCR4, macrophage migration inhibitory factor (MIF) receptors, mediate bladder pain.
<h4>Background</h4>Activation of intravesical protease activated receptor 4 (PAR4) leads to release of urothelial macrophage migration inhibitory factor (MIF). MIF then binds to urothelial MIF receptors to release urothelial high mobility group box-1 (HMGB1) and elicit bladder hyperalges...
Enregistré dans:
Auteurs principaux: | Shaojing Ye, Fei Ma, Dlovan F D Mahmood, Katherine L Meyer-Siegler, Raymond E Menard, David E Hunt, Lin Leng, Richard Bucala, Pedro L Vera |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7fc27f72d7f44943824ab56be9a0a3f1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies
par: Jin X, et autres
Publié: (2016) -
Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis
par: Hirohito Kanemitsu, et autres
Publié: (2009) -
Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
par: Mi Ah Han, et autres
Publié: (2021) -
Role of the Macrophage Migration Inhibitory Factor (MIF) in the survival of first trimester human placenta under induced stress conditions
par: Francesca Ietta, et autres
Publié: (2018) -
Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer
par: Suo N, et autres
Publié: (2019)